Company Name: |
Sigma-Aldrich
|
Tel: |
021-61415566 800-8193336 |
Email: |
orderCN@merckgroup.com |
Products Intro: |
Product Name:Epidermal Growth Factor Receptor Purity:lyophilized powder, main >= 15,000units/mg protein Bradford Package:500units Remarks:E2645
|
|
| EPIDERMAL GROWTH FACTOR RECEPTOR Basic information |
Product Name: | EPIDERMAL GROWTH FACTOR RECEPTOR | Synonyms: | EGF-R;EGF RECEPTOR;EPIDERMAL GROWTH FACTOR RECEPTOR;EGFR (L861Q), active, GST tagged human;EGFR (695-end), active, GST tagged human;mENA;EGFR active mouse;ERBB | CAS: | | MF: | | MW: | 0 | EINECS: | | Product Categories: | | Mol File: | Mol File | |
| EPIDERMAL GROWTH FACTOR RECEPTOR Chemical Properties |
storage temp. | -70°C | form | lyophilized powder |
Hazard Codes | B | WGK Germany | 3 |
| EPIDERMAL GROWTH FACTOR RECEPTOR Usage And Synthesis |
Description | EGFR (HER1, ErbB1) is an RTK expressed on the surface of cells of mesodermal and ectodermal origin, and it mediates cell growth, proliferation, and differentiation in numerous organs [16, 17]. EGFR belongs to the ErbB family of RTKs,
which also includes HER2 (ErbB2), HER3 (ErbB3), and HER4 (ErbB4). EGFR
binds at least seven highly variable growth factor ligands [18]. Upon stimulation,
EGFR undergoes combinatorial homo- or hetero-dimerization with one of the proteins of the HER family, thereby activating an expansive signaling network [16, 19,
20]. The EGFR transmembrane protein has a large extracellular component (with 4
domains, ~620 amino acids) that primarily serves as ligand-binding sites and which
is anchored by a short helical transmembrane domain to the intracellular tyrosine
kinase domain (TKD) (Fig.?1) [18]. | Mechanism of action | EGFR is believed to play a role in the pathogenesis of lung cancer and is overexpressed in a majority of NSCLCs [21, 22]. However, the clinical importance of
EGFR expression in the general NSCLC population is unclear. There was some
suggestion that EGFR expression may serve as a predictive biomarker [21], but this
has been superseded by mutational analysis after the identification of actionable
driver mutations in the EGFR gene. |
| EPIDERMAL GROWTH FACTOR RECEPTOR Preparation Products And Raw materials |
|